1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Denmark >
  5. Brygge Partners Acquires Pharma-Skan

M&A Deal Summary

Brygge Partners Acquires Pharma-Skan

On April 1, 2025, private equity firm Brygge Partners acquired life science company Pharma-Skan

Acquisition Highlights
  • This is Brygge Partners’ 1st transaction in the Life Science sector.
  • This is Brygge Partners’ 12th transaction in Denmark.

M&A Deal Summary
Date 2025-04-01
Target Pharma-Skan
Sector Life Science
Buyer(s) Brygge Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Pharma-Skan

Skanderborg, Denmark
Pharma-Skan is an independent contract manufacturer (CMO) for the pharmaceutical industry and serves international customers with niche production of high complexity and documentation requirements. Pharma-Skan was founded in 1992 and is based in Skanderborg, Denmark.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Brygge Partners

Category Private Equity Firm
Founded 2017
Size Small
Type Sector Agnostic
DESCRIPTION

Brygge Partners is a private equity firm focused on acquiring and investing in lower middle-market Danish companies. Brygge Partners was established in 2017 and is based in Esbjerg.

DEAL STATS #
Overall 12 of 12
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 5 of 5
Country: Denmark M&A 12 of 12
Year: 2025 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-04-01 Skan-Medic

Skanderborg, Denmark

Skan-Medic produces creams, lotions and other consumer products, primarily for pharmacies. Skan-Medic products are developed with pharmaceutical care, mild ingredients and care for both you and your skin Skan-Medic is based in Skanderborg, Denmark.

Buy -
Mergr

Solution for

Product

Company

Legal